首页> 外文期刊>World Journal of Gastroenterology >Apoptosis induced by preoperative oral 5'-DFUR administration in gastric adenocarcinoma and its mechanism of action.
【24h】

Apoptosis induced by preoperative oral 5'-DFUR administration in gastric adenocarcinoma and its mechanism of action.

机译:胃腺癌术前口服5'-DFUR诱导的细胞凋亡及其作用机理。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To study the apoptosis induced by preoperative oral 5'-DFUR administration in gastric adenocarcinoma and its mechanism of action. METHODS: Sixty gastric cancer patients were divided randomly into three groups (20 each group) before operation: group one:5'-DFUR oral administration at the dose of 800-1200 mg/d for 3 - 5 d, group two: 500 mg 5-FU + 200 mg/d CF by venous drip for 3 - 5 d,group three (control group). One or two days after chemotherapy, the patients were operated. Fas/FasL,PD-ECGF and PCNA were examined by immunohistochemistry and apoptotic tumor cells were detected by in situ TUNEL method. Fifty-four patients received gastrectomy, including 12 palliative resections and 42 radical resections. Six patients were excluded. Finally 18 cases in 5'-DFUR group, 16 cases in CF+5-FU group, and 20 cases in control group were analyzed. RESULTS: There was no significant difference in patient mean age, gender, white blood cell count, haematoglobin (HB),thromboplastin, perioperative complication incidence, radical or palliation resection, invasion depth (T), lymphonode involvement (N),metastasis (M) and TNM staging among the three groups. However,the PCNA index (PI) in 5'-DFUR group (40.51+/-12.62) and 5-FU+CF group (41.12+/-15.26) was significantly lower than that in control group (58.33+/-15.69) (F=9.083, P=0.000). The apoptotic index (AI) in 5'-DFUR group (14.39+/-9.49) and 5-FU+CF group (14.11+/-9.68)was significantly higher than that in control group (6.88+/-7.37) (F=4.409, P=0.017).The expression rates of Fas and FasL in group one and group three were 66.7% (12/18) and 50% (9/18), 43.8% (7/16) and 81.3% (13/16), 45.0% (9/20) and 85% (17/20), respectively. The expression rate of FasL in 5'-DFUR group was significantly lower than that in the other two groups (chi2=6.708, P=0.035). Meanwhile, the expression rate of PD-ECGF was significantly lower in 5'-DFUR group (4/18,28.6%) than in CF+5-FU group(9/16,56.3%)and control group (13/20,65.0%) (chi2=7.542, P=0.023). The frequency of Fas expression wassignificantly correlated with palliative or radical resection (chi2=7.651, P=0.006), invasion depth (chi2=8.927, P=0.003), lymphatic spread (chi2=4.488, P=0.034) and UICC stages (chi2=8.063, P=0.045) respectively. By the end of March 2005,45 patients were followed up. The 0.5-, 1-, 2-, 3-year survival rates were 96%,73%,60%,48%, respectively, which were related with T, N, M and Fas expression, but not with PD-ECGF and FasL expression. CONCLUSION: Preoperative oral 5'-DFUR administration may induce apoptosis of gastric carcinoma cells and decrease tumor cell proliferation index,but cannot improve the prognosis of patients with gastric cancer.Down-regulation of FasL and PD-ECGF expression mediated by 5'-DFUR may be one of its anti-cancer mechanisms.Fas expression correlates with the progression of gastric carcinoma and may be an effective prognostic factor.
机译:目的:研究术前口服5'-DFUR引起的胃腺癌细胞凋亡及其作用机制。方法:将60例胃癌患者在手术前随机分为三组(每组20例):第一组:5'-DFUR口服,剂量为800-1200 mg / d,持续3-5天,第二组:500 mg静脉滴注5-FU + 200 mg / d CF 3-5 d,第三组(对照组)。化疗后一到两天,患者进行了手术。免疫组化法检测Fas / FasL,PD-ECGF和PCNA,原位TUNEL法检测凋亡细胞。 54例患者接受了胃切除术,包括12例姑息性切除和42例根治性切除。排除了六名患者。最后分析了5'-DFUR组的18例,CF + 5-FU组的16例,对照组的20例。结果:患者平均年龄,性别,白细胞计数,血红蛋白(HB),凝血活酶,围手术期并发症发生率,根治或缓解切除,浸润深度(T),淋巴结受累(N),转移灶(M)均无显着差异。 )和三组之间的TNM分期。然而,5'-DFUR组(40.51 +/- 12.62)和5-FU + CF组(41.12 +/- 15.26)的PCNA指数(PI)显着低于对照组(58.33 +/- 15.69) (F = 9.083,P = 0.000)。 5'-DFUR组(14.39 +/- 9.49)和5-FU + CF组(14.11 +/- 9.68)的凋亡指数(AI)显着高于对照组(6.88 +/- 7.37)(F = 4.409,P = 0.017)。第一和第三组Fas和FasL的表达率分别为66.7%(12/18)和50%(9/18),43.8%(7/16)和81.3%(13 /16)、45.0%(9/20)和85%(17/20)。 5'-DFUR组FasL的表达率明显低于其他两组(chi2 = 6.708,P = 0.035)。同时,PD-ECGF的表达率在5'-DFUR组(4 / 18,28.6%)显着低于CF + 5-FU组(9 / 16,56.3%)和对照组(13/20, 65.0%)(chi2 = 7.542,P = 0.023)。 Fas表达的频率与姑息性或根治性切除(chi2 = 7.651,P = 0.006),浸润深度(chi2 = 8.927,P = 0.003),淋巴管扩散(chi2 = 4.488,P = 0.034)和UICC分期(chi2)显着相关。 = 8.063,P = 0.045)。截至2005年3月,已对45例患者进行了随访。 0.5、1、2、3年生存率分别为96%,73%,6​​0%,48%,与T,N,M和Fas表达有关,而与PD-ECGF和FasL表达。结论:术前口服5'-DFUR可能诱导胃癌细胞凋亡,降低肿瘤细胞的增殖指数,但不能改善胃癌患者的预后。5'-DFUR介导的FasL和PD-ECGF表达下调Fas的表达与胃癌的进展有关,可能是一种有效的预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号